• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经尿道前列腺切除术的现状:一项韩国多中心研究

Current status of transurethral prostatectomy: a korean multicenter study.

作者信息

Jang Dong Gyu, Yoo Changhee, Oh Cheol Young, Kim Se Joong, Kim Sun Il, Kim Chun Il, Kim Hong Sup, Park Jong Yeon, Seong Do Hwan, Song Yun Seob, Yang Won Jae, Cho In Rae, Cho Sung Yong, Cheon Sang Hyeon, Im Hyoungjune, Cho Jin Seon

机构信息

Department of Urology, College of Medicine, Hallym University, Chuncheon, Korea.

出版信息

Korean J Urol. 2011 Jun;52(6):406-9. doi: 10.4111/kju.2011.52.6.406. Epub 2011 Jun 17.

DOI:10.4111/kju.2011.52.6.406
PMID:21750752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3123817/
Abstract

PURPOSE

We aimed to verify the current status of transurethral resection of the prostate (TURP) in Korea.

MATERIALS AND METHODS

The medical records of 1,341 men who underwent TURP in 9 Korean medical centers between 2004 and 2008 were reviewed. The patients were divided into two groups according to time periods: 2004-2005 (group 1) and 2006-2008 (group 2). To verify differences in the two patient groups, age, prostate volume, indications for TURP, preoperative International Prostate Symptom Score (IPSS), and resected tissue weight were evaluated.

RESULTS

The mean age of the patients was 71.2 years and the mean IPSS was 22.7. The patients' characteristics were not significantly different between the two groups. The annual cases of TURP increased over the study period. The proportion of lower urinary tract symptoms (LUTS) as an indication for TURP increased up to 58.3% in group 2 compared with 51.6% in group 1 (p=0.019). However, the proportion of patients who presented with acute urinary retention decreased from 35.5% to 30.3% with marginal statistical significance (p=0.051). Other indications such as hematuria, bladder stone, recurrent urinary tract infection, and hydronephrosis were not significantly different between the groups. The mean resected weights of the prostate were similar (17.5 g in group 1 and 18.3 g in group 2, respectively; p>0.05).

CONCLUSIONS

TURP has been steadily performed in patients with benign prostatic hyperplasia and it is expected to remain constant. LUTS was the most common indication for TURP in recent years.

摘要

目的

我们旨在核实韩国经尿道前列腺切除术(TURP)的当前状况。

材料与方法

回顾了2004年至2008年间在9家韩国医疗中心接受TURP的1341名男性的病历。根据时间段将患者分为两组:2004 - 2005年(第1组)和2006 - 2008年(第2组)。为了验证两组患者的差异,评估了年龄、前列腺体积、TURP的适应症、术前国际前列腺症状评分(IPSS)以及切除组织重量。

结果

患者的平均年龄为71.2岁,平均IPSS为22.7。两组患者的特征无显著差异。在研究期间,TURP的年度病例数有所增加。作为TURP适应症的下尿路症状(LUTS)比例在第2组中增至58.3%,而在第1组中为51.6%(p = 0.019)。然而,出现急性尿潴留的患者比例从35.5%降至30.3%,具有边缘统计学意义(p = 0.051)。血尿、膀胱结石、复发性尿路感染和肾积水等其他适应症在两组之间无显著差异。前列腺的平均切除重量相似(第1组为17.5克,第2组为18.3克,分别;p>0.05)。

结论

TURP一直在良性前列腺增生患者中稳定开展,预计将保持稳定。近年来,LUTS是TURP最常见的适应症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/026f/3123817/afc26320a547/kju-52-406-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/026f/3123817/afc26320a547/kju-52-406-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/026f/3123817/afc26320a547/kju-52-406-g001.jpg

相似文献

1
Current status of transurethral prostatectomy: a korean multicenter study.经尿道前列腺切除术的现状:一项韩国多中心研究
Korean J Urol. 2011 Jun;52(6):406-9. doi: 10.4111/kju.2011.52.6.406. Epub 2011 Jun 17.
2
Microwave thermotherapy for benign prostatic hyperplasia.良性前列腺增生的微波热疗
Cochrane Database Syst Rev. 2012 Sep 12(9):CD004135. doi: 10.1002/14651858.CD004135.pub3.
3
Microwave thermotherapy for benign prostatic hyperplasia.微波热疗治疗良性前列腺增生症。
Cochrane Database Syst Rev. 2007 Oct 17(4):CD004135. doi: 10.1002/14651858.CD004135.pub2.
4
Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study).前列腺动脉栓塞治疗良性前列腺增生症的疗效和安全性:一项观察性研究及与经尿道前列腺切除术的倾向评分匹配比较(英国-ROPE 研究)。
BJU Int. 2018 Aug;122(2):270-282. doi: 10.1111/bju.14249. Epub 2018 May 6.
5
Randomized study of transurethral resection of the prostate and combined transurethral resection and vaporization of the prostate as a therapeutic alternative in men with benign prostatic hyperplasia.经尿道前列腺切除术与经尿道前列腺切除术联合汽化术治疗良性前列腺增生症男性患者的随机对照研究。
J Endourol. 2001 Apr;15(3):317-21. doi: 10.1089/089277901750161935.
6
A 10-year follow-up after transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia; long-term results of a randomized controlled trial.良性前列腺增生经尿道前列腺切除术、接触式激光前列腺切除术和电汽化术 10 年随访;一项随机对照试验的长期结果。
BJU Int. 2010 Sep;106(6):822-6. doi: 10.1111/j.1464-410X.2010.09229.x. Epub 2010 Feb 22.
7
Comparison of effectiveness of monopolar and bipolar transurethral resection of the prostate and open prostatectomy in large benign prostatic hyperplasia.单极与双极经尿道前列腺切除术及开放性前列腺切除术治疗巨大良性前列腺增生症的疗效比较
Korean J Urol. 2011 Apr;52(4):269-73. doi: 10.4111/kju.2011.52.4.269. Epub 2011 Apr 22.
8
Usage of GreenLight HPS 180-W laser vaporisation for treatment of benign prostatic hyperplasia.使用绿激光HPS 180-W激光汽化术治疗良性前列腺增生症。
Acta Chir Iugosl. 2014;61(1):57-61.
9
Modified transurethral resection of the prostate (TURP) for men with moderate lower urinary tract symptoms (LUTS) before brachytherapy is safe and feasible.对于接受近距离放射治疗前有中度下尿路症状(LUTS)的男性,改良经尿道前列腺切除术(TURP)是安全可行的。
BJU Int. 2015 Apr;115(4):580-6. doi: 10.1111/bju.12798. Epub 2014 Dec 15.
10
Comparison of Hiraoka's Transurethral Detachment Prostatectomy and Transurethral Resection of the Prostate Effects on Postoperative Erectile Function in Patients With Benign Prostatic Hyperplasia: A Prospective Randomized Controlled Study.比较经尿道前列腺电切术与经尿道前列腺剜除术对良性前列腺增生症患者术后勃起功能的影响:一项前瞻性随机对照研究。
J Sex Med. 2020 Nov;17(11):2181-2190. doi: 10.1016/j.jsxm.2020.06.001. Epub 2020 Jul 19.

引用本文的文献

1
Recent Patterns and Trends in Global Prostate Cancer Incidence and Mortality: An Update.全球前列腺癌发病率和死亡率的近期模式与趋势:最新情况
Eur Urol. 2025 Mar;87(3):302-313. doi: 10.1016/j.eururo.2024.11.013. Epub 2024 Dec 11.
2
The effect of complete transurethral resection of the prostate on symptoms, quality of life, and voiding function improvement.前列腺完全经尿道切除术对症状、生活质量及排尿功能改善的影响。
Cent European J Urol. 2015;68(2):169-74. doi: 10.5173/ceju.2015.507. Epub 2015 Mar 31.
3
Effect of Transurethral Resection of the Prostate on Storage Symptoms in Patients with Benign Prostatic Hyperplasia of Less than 30 ml.

本文引用的文献

1
Changes in surgical strategy for patients with benign prostatic hyperplasia: 12-year single-center experience.良性前列腺增生患者手术策略的变化:12年单中心经验
Korean J Urol. 2011 Mar;52(3):189-93. doi: 10.4111/kju.2011.52.3.189. Epub 2011 Mar 18.
2
Current laser treatments for benign prostatic hyperplasia.当前用于良性前列腺增生的激光治疗方法。
Korean J Urol. 2010 Nov;51(11):737-44. doi: 10.4111/kju.2010.51.11.737. Epub 2010 Nov 17.
3
The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study.
经尿道前列腺切除术治疗前列腺体积小于 30ml 的良性前列腺增生患者的储尿症状的效果。
World J Mens Health. 2013 Apr;31(1):64-9. doi: 10.5534/wjmh.2013.31.1.64. Epub 2013 Apr 23.
4
Benign prostatic hyperplasia: from bench to clinic.良性前列腺增生:从实验室到临床
Korean J Urol. 2012 Mar;53(3):139-48. doi: 10.4111/kju.2012.53.3.139. Epub 2012 Mar 19.
度他雄胺和坦索罗辛联合治疗对有症状的良性前列腺增生症男性临床结局的影响:来自 CombAT 研究的 4 年结果。
Eur Urol. 2010 Jan;57(1):123-31. doi: 10.1016/j.eururo.2009.09.035. Epub 2009 Sep 19.
4
Treatment and pharmacologic management of BPH in the context of common comorbidities.常见合并症背景下良性前列腺增生症的治疗与药物管理
Am J Manag Care. 2006 Apr;12(5 Suppl):S129-40.
5
The changing practice of transurethral prostatectomy: a comparison of cases performed in 1990 and 2000.经尿道前列腺切除术的实践变迁:1990年与2000年病例对比
Ann R Coll Surg Engl. 2004 Nov;86(6):428-31. doi: 10.1308/147870804731.
6
The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia.多沙唑嗪、非那雄胺及联合治疗对良性前列腺增生临床进展的长期影响。
N Engl J Med. 2003 Dec 18;349(25):2387-98. doi: 10.1056/NEJMoa030656.
7
AUA guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations.美国泌尿外科学会良性前列腺增生管理指南(2003年)。第1章:诊断与治疗建议。
J Urol. 2003 Aug;170(2 Pt 1):530-47. doi: 10.1097/01.ju.0000078083.38675.79.
8
Immediate and postoperative complications of transurethral prostatectomy in the 1990s.20世纪90年代经尿道前列腺切除术的即刻及术后并发症
J Urol. 1999 Oct;162(4):1307-10.
9
Is transurethral resection of the prostate still justified?经尿道前列腺切除术是否仍合理?
BJU Int. 1999 Feb;83(3):227-37. doi: 10.1046/j.1464-410x.1999.00908.x.
10
The treatment of gross hematuria secondary to prostatic bleeding with finasteride.非那雄胺治疗前列腺出血继发的肉眼血尿
J Urol. 1998 Apr;159(4):1232-3.